ALPS ADVISORS INC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 106 filers reported holding ASCENDIS PHARMA A/S in Q4 2018. The put-call ratio across all filers is 0.16 and the average weighting 1.0%.

Quarter-by-quarter ownership
ALPS ADVISORS INC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2022$3,141,000
+10.3%
30,416
-0.7%
0.03%
+7.1%
Q2 2022$2,847,000
-65.7%
30,630
-56.5%
0.03%
-52.5%
Q1 2019$8,294,000
+36.3%
70,468
-27.5%
0.06%
+25.5%
Q4 2018$6,086,000
+31.2%
97,135
+48.4%
0.05%
+56.7%
Q3 2018$4,638,000
+30.8%
65,448
+22.7%
0.03%
+30.4%
Q2 2018$3,547,000
+11.2%
53,324
+9.3%
0.02%
-8.0%
Q1 2018$3,190,000
+97.6%
48,775
+21.0%
0.02%
+127.3%
Q4 2017$1,614,000
+39.5%
40,297
+26.2%
0.01%
+37.5%
Q3 2017$1,157,000
+42.5%
31,929
+9.1%
0.01%
+33.3%
Q2 2017$812,000
+7.0%
29,264
+7.9%
0.01%
+20.0%
Q1 2017$759,000
+23.8%
27,120
-10.5%
0.01%0.0%
Q4 2016$613,000
+17.0%
30,296
+7.2%
0.01%0.0%
Q1 2016$524,000
-13.5%
28,259
-14.6%
0.01%
-16.7%
Q4 2015$606,000
-90.8%
33,102
-11.3%
0.01%
-14.3%
Q3 2015$6,604,000
+1491.3%
37,310
+57.9%
0.01%
+75.0%
Q2 2015$415,00023,6260.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2018
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders